サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1338919

ダリエー病市場、シェア、市場規模、動向、産業分析レポート：治療法別、用途別、エンドユーザー別、地域別、セグメント別予測、2023-2032年

Darier Disease Market Share, Size, Trends, Industry Analysis Report, By Treatment (Medication, Surgery, and Others); By Application; By End- User; By Region; Segment Forecast, 2023-2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 112 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
ダリエー病市場、シェア、市場規模、動向、産業分析レポート：治療法別、用途別、エンドユーザー別、地域別、セグメント別予測、2023-2032年
出版日: 2023年06月23日
発行: Polaris Market Research
ページ情報: 英文 112 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界のダリエー病市場規模は2032年までに7,412万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

ダリエー病は、新たなヘルスケア動向の出現に伴って広まると予測されます。この疾患の副作用に対処するため、より多くの皮膚科治療が利用できるようになり、研究者は新しい治療法を生み出すために多額の財政支援を受けることになると思われます。ダリエー病（毛包性角化症）は、ATP2A2遺伝子の変異によって引き起こされるまれな遺伝性皮膚疾患です。この疾患は、典型的には頭皮、額、胸、背中、その他の体の部位に現れるイボ状の丘疹や斑を特徴とします。

この疾患の希少性から、ダリエー病の市場は極めて小さいです。しかし、キャッスル・クリーク・ファーマシューティカルズやホス・セラピューティクスを含む特定の企業は、珍しい皮膚疾患の治療法の開発に注力しています。レチノイドやカルシニューリン阻害剤など、ダリエー病の治療に使用される薬剤のいくつかは、他の皮膚疾患の治療にも使用されているという事実は、これらの薬剤の市場を拡大するのに役立つかもしれないです。

しかし、患者数が少なく、希少疾患治療薬の開発コストが高いため、この分野に投資する企業の数は限られるかもしれないです。COVID-19の流行はヘルスケア業界に大きな影響を与えており、多くの医療提供者や施設がCOVID-19患者の治療に専念しています。そのため、ダリエー病のような希少疾患を含む他の病状の診断や治療に遅れが生じています。さらに、パンデミックは臨床試験や医薬品開発プログラムを中断させ、ダリエー病に対する新たな治療法の入手に影響を与える可能性があります。安全性への懸念やヘルスケア施設への患者のアクセス制限のため、多くの臨床試験が遅延または中断しています。

ダリエー病市場レポートハイライト

予測期間中、外科手術が業界の市場分野を支配すると予想されます。痛みや不快感を軽減しながら結果を改善する外科手術の能力が、業界拡大の主な要因です。

外用レチノイドは、今後1年間は市場で高いシェアを占めると思われます。症状の治療におけるこれらの薬剤の有効性により、市場促進要因として今後数年間の成長が予測されます。

皮膚科医は2022年に最大のシェアを占めました。彼らは処方を担当し、患者サポートを提供し、この病気の治療において重要な役割を果たしているため、市場に影響を与える主要な力となっています。

北米の需要は予測期間中に大幅な成長が見込まれます。市場の主な促進要因は、ヘルスケアサービスの選択肢の拡大や医療費の上昇など、多くの要因の結果、今後数年間で上昇すると予測されます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のダリエー病市場に関する洞察

  • ダリエー病市場- エンドユーザーのスナップショット
  • ダリエー病市場力学
    • 促進要因と機会
      • 再生可能エネルギー源の需要の増加
      • 電力消費需要の増加
    • 抑制要因と課題
      • 初期費用が高い
  • PESTEL分析
  • ダリエー病市場のエンドユーザー動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界のダリエー病市場、治療別

  • 主な調査結果
  • イントロダクション
  • 医学
  • 手術
  • その他

第6章 世界のダリエ疾患市場、用途別

  • 主な調査結果
  • イントロダクション
  • 局所レチノイド
  • 経口レチノイド
  • その他

第7章 世界のダリエ疾患市場、エンドユーザー別

  • 主な調査結果
  • イントロダクション
  • 皮膚科医
  • ホームケア
  • 病院
  • 専門クリニック

第8章 世界のダリエー病市場、地域別

  • 主な調査結果
  • イントロダクション
    • ダリエー病市場評価、地域別、2019-2032年
  • ダリエー病市場-北米
    • 北米：ダリエー病市場、治療別、2019-2032年
    • 北米：ダリエー病市場、エンドユーザー別、2019～2032年
    • 北米：ダリエー病市場、用途別、2019～2032年
    • ダリエー病市場-米国
    • ダリエー病市場- カナダ
  • ダリエー病市場- 欧州
    • 欧州：ダリエー病市場、治療別、2019～2032年
    • 欧州：ダリエ疾患市場、エンドユーザー別、2019～2032年
    • 欧州：ダリエー病市場、用途別、2019～2032年
    • ダリエー病市場- 英国
    • ダリエー病市場- フランス
    • ダリエー病市場- ドイツ
    • ダリエー病市場- イタリア
    • ダリエー病市場- スペイン
    • ダリエー病市場- オランダ
    • ダリエー病市場- ロシア
  • ダリエー病市場- アジア太平洋
    • アジア太平洋：ダリエー病市場、治療別、2019～2032年
    • アジア太平洋：ダリエ疾患市場、エンドユーザー別、2019～2032年
    • アジア太平洋：ダリエ疾患市場、用途別、2019～2032年
    • ダリエー病市場- 中国
    • ダリエー病市場- インド
    • ダリエー病市場- マレーシア
    • ダリエー病市場- 日本
    • ダリエー病市場- インドネシア
    • ダリエー病市場- 韓国
  • ダリエー病市場-中東およびアフリカ
    • 中東およびアフリカ：ダリエー病市場、治療別、2019～2032年
    • 中東およびアフリカ：ダリエー病市場、エンドユーザー別、2019～2032年
    • 中東およびアフリカ：ダリエー病市場、用途別、2019～2032年
    • ダリエー病市場- サウジアラビア
    • ダリエー病市場- アラブ首長国連邦
    • ダリエー病市場- イスラエル
    • ダリエー病市場- 南アフリカ
  • ダリエー病市場-ラテンアメリカ
    • ラテンアメリカ：ダリエー病市場、治療別、2019-2032年
    • ラテンアメリカ：ダリエー病市場、エンドユーザー別、2019～2032年
    • ラテンアメリカ：ダリエー病市場、用途別、2019-2032年
    • ダリエー病市場- メキシコ
    • ダリエー病市場- ブラジル
    • ダリエー病市場- アルゼンチン

第9章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • AbbVie
  • Amneal Pharmaceuticals
  • Bausch Health Companies
  • BridgeBio Pharma
  • Galderma
  • GlaxoSmithKline
  • Glenmark Pharmaceuticals
  • Johnson and Johnson
  • Laminar Pharma
  • Mayne Pharma
  • Merck
  • Novartis
  • Pfizer
  • Sawai Pharmaceutical
  • Sigmapharm Laboratories
  • Sun Pharmaceutical
  • Teva Pharmaceutical
  • Tolmar Pharmaceuticals
  • Validus Pharmaceuticals
  • Viatris
図表

List of Tables

  • Table 1 Global Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 2 Global Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 3 Global Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 4 Darier Disease Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 6 North America: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 7 North America: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 8 U.S.: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 9 U.S.: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 10 U.S.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 11 Canada: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 12 Canada: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 13 Canada: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 14 Europe: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 15 Europe: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 16 Europe: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 17 UK: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 18 UK: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 19 UK: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 20 France: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 21 France: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 22 France: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 23 Germany: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 24 Germany: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 25 Germany: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 26 Italy: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 27 Italy: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 28 Italy: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 29 Spain: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 30 Spain: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 31 Spain: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 32 Netherlands: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 33 Netherlands: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 34 Netherlands: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 35 Russia: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 36 Russia: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 37 Russia: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 41 China: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 42 China: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 43 China: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 44 India: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 45 India: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 46 India: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 47 Malaysia: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 48 Malaysia: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 49 Malaysia: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 50 Japan: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 51 Japan: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 52 Japan: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 53 Indonesia: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 54 Indonesia: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 55 Indonesia: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 56 South Korea: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 57 South Korea: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 58 South Korea: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 65 UAE: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 66 UAE: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 67 UAE: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 68 Israel: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 69 Israel: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 70 Israel: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 71 South Africa: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 72 South Africa: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 73 South Africa: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 74 Latin America: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 75 Latin America: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 76 Latin America: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 77 Mexico: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 78 Mexico: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 79 Mexico: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 80 Brazil: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 81 Brazil: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 82 Brazil: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 83 Argentina: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 84 Argentina: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 85 Argentina: Darier Disease Market, by End- User, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Darier Disease Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Application
  • Figure 7. Global Darier Disease Market, by Application, 2022 & 2032 (USD Million)
  • Figure 8. Market by Treatment
  • Figure 9. Global Darier Disease Market, by Treatment, 2022 & 2032 (USD Million)
  • Figure 10. Market by End- User
  • Figure 11. Global Darier Disease Market, by End- User, 2022 & 2032 (USD Million)
  • Figure 12. Darier Disease Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Darier Disease Market
目次
Product Code: PM3363

The global darier disease market size is expected to reach USD 74.12 million by 2032, according to a new study by Polaris Market Research. The report "Darier Disease Market Share, Size, Trends, Industry Analysis Report, By Treatment (Medication, Surgery, and Others); By Application; By End- Use; By Region; Segment Forecast, 2023-2032" gives a detailed insight into the current market dynamics and provides analysis on future market growth.

Darier disease is anticipated to spread as new healthcare trends emerge. More dermatological treatments will be available to address the condition's side effects, and researchers will receive sizeable financial support to create novel remedies. Darier disease, or keratosis follicularis, is a rare genetic skin disorder caused by mutations in the ATP2A2 gene. The disease is characterized by wart-like papules and plaques that typically appear on the scalp, forehead, chest, back, and other body areas.

Due to the condition's rarity, the market for Darier disease is quite small. Yet, certain businesses, including Castle Creek Pharmaceuticals & Hoth Therapeutics, are focused on creating treatments for uncommon skin conditions. The fact that some of the medications used to treat Darier disease, including retinoids and calcineurin inhibitors, are also used to treat other skin disorders may help to increase the market for these medications.

However, the small patient population and the high cost of developing rare disease therapies may limit the number of companies investing in this area. The COVID-19 pandemic has significantly impacted the healthcare industry, with many healthcare providers and facilities focused on treating patients with COVID-19. This has led to delays in diagnosing and treating other medical conditions, including rare diseases like Darier disease. Additionally, the pandemic has disrupted clinical trials and drug development programs, which may impact the availability of new treatments for Darier disease. Many trials have been delayed or suspended due to safety concerns and restrictions on patient access to healthcare facilities.

Darier Disease Market Report Highlights

Surgery is expected to dominate the industry's market sector during forecast period. The ability of the surgical industry to reduce pain and discomfort while improving results is the major factor driving its expansion.

Topical Retinoid will account for a higher share of the market in the upcoming year. Due to the effectiveness of these medications in treating the condition's symptoms, the primary driver driving the market is predicted to grow over the next several years.

Dermatologist accounted for the largest share in 2022. They are the primary force influencing the market because they are in charge of prescribing, offering patient support, and playing a crucial part in the care of this ailment.

The demand in North America is expected to witness significant growth during forecast period. The primary driver of the market is anticipated to rise in the upcoming years as a result of a number of factors, including the expansion of healthcare service options and rising healthcare costs.

Polaris Market Research has segmented the Darier Disease Market report based on treatment, application, end- user and region:

Darier Disease, Treatment Outlook (Revenue - USD Million, 2019 - 2032)

  • Medical
  • Surgery
  • Others

Darier Disease, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Topical Retinoids
  • Oral Retinoids
  • Others

Darier Disease, End- User Outlook (Revenue - USD Million, 2019 - 2032)

  • Dermatologist
  • Homecare
  • Hospitals
  • Specialty Clinics

Darier Disease, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Darier Disease Market Insights

  • 4.1. Darier Disease Market - End- User Snapshot
  • 4.2. Darier Disease Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increase in demand for renewable sources of energy
      • 4.2.1.2. Rise in demand for electricity consumption
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High initial costs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Darier Disease Market End- User Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Darier Disease Market, by Treatment

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • 5.3. Medical
    • 5.3.1. Global Darier Disease Market, by Medical, by Region, 2019-2032 (USD Million)
  • 5.4. Surgery
    • 5.4.1. Global Darier Disease Market, by Surgery, by Region, 2019-2032 (USD Million)
  • 5.5. Others
    • 5.5.1. Global Darier Disease Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Darier Disease Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Darier Disease Market, by Application, 2019-2032 (USD Million)
  • 6.3. Topical Retinoids
    • 6.3.1. Global Darier Disease Market, by Topical Retinoids, by Region, 2019-2032 (USD Million)
  • 6.4. Oral Retinoids
    • 6.4.1. Global Darier Disease Market, by Oral Retinoids, by Region, 2019-2032 (USD Million)
  • 6.5. Others
    • 6.5.1. Global Darier Disease Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Darier Disease Market, by End- User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • 7.3. Dermatologist
    • 7.3.1. Global Darier Disease Market, by Dermatologist, By Region, 2019-2032 (USD Million)
  • 7.4. Homecare
    • 7.4.1. Global Darier Disease Market, by Homecare, By Region, 2019-2032 (USD Million)
  • 7.5. Hospitals
    • 7.5.1. Global Darier Disease Market, by Hospitals, By Region, 2019-2032 (USD Million)
  • 7.6. Specialty Clinics
    • 7.6.1. Global Darier Disease Market, by Specialty Clinics, By Region, 2019-2032 (USD Million)

8. Global Darier Disease Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Darier Disease Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Darier Disease Market - North America
    • 8.3.1. North America: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
    • 8.3.2. North America: Darier Disease Market, by End- User, 2019-2032 (USD Million)
    • 8.3.3. North America: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.3.4. Darier Disease Market - U.S.
      • 8.3.4.1. U.S.: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.3.5. Darier Disease Market - Canada
      • 8.3.5.1. Canada: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • 8.4. Darier Disease Market - Europe
    • 8.4.1. Europe: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
    • 8.4.3. Europe: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.4.4. Darier Disease Market - UK
      • 8.4.4.1. UK: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.4.5. Darier Disease Market - France
      • 8.4.5.1. France: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.4.5.3. France: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.4.6. Darier Disease Market - Germany
      • 8.4.6.1. Germany: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.4.7. Darier Disease Market - Italy
      • 8.4.7.1. Italy: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.4.8. Darier Disease Market - Spain
      • 8.4.8.1. Spain: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.4.9. Darier Disease Market - Netherlands
      • 8.4.9.1. Netherlands: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.4.10. Darier Disease Market - Russia
      • 8.4.10.1. Russia: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • 8.5. Darier Disease Market - Asia Pacific
    • 8.5.1. Asia Pacific: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.5.4. Darier Disease Market - China
      • 8.5.4.1. China: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.5.4.3. China: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.5.5. Darier Disease Market - India
      • 8.5.5.1. India: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.5.5.3. India: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.5.6. Darier Disease Market - Malaysia
      • 8.5.6.1. Malaysia: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.5.7. Darier Disease Market - Japan
      • 8.5.7.1. Japan: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.5.8. Darier Disease Market - Indonesia
      • 8.5.8.1. Indonesia: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.5.9. Darier Disease Market - South Korea
      • 8.5.9.1. South Korea: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • 8.6. Darier Disease Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.6.4. Darier Disease Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.6.5. Darier Disease Market - UAE
      • 8.6.5.1. UAE: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.6.6. Darier Disease Market - Israel
      • 8.6.6.1. Israel: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.6.7. Darier Disease Market - South Africa
      • 8.6.7.1. South Africa: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • 8.7. Darier Disease Market - Latin America
    • 8.7.1. Latin America: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.7.4. Darier Disease Market - Mexico
      • 8.7.4.1. Mexico: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.7.5. Darier Disease Market - Brazil
      • 8.7.5.1. Brazil: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.7.6. Darier Disease Market - Argentina
      • 8.7.6.1. Argentina: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Darier Disease Market, by Application, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. AbbVie
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Amneal Pharmaceuticals
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Bausch Health Companies
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. BridgeBio Pharma
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Galderma
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. GlaxoSmithKline
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Glenmark Pharmaceuticals
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Johnson and Johnson
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Laminar Pharma
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Mayne Pharma
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Merck
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Novartis
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Pfizer
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Sawai Pharmaceutical
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Sigmapharm Laboratories
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development
  • 10.16. Sun Pharmaceutical
    • 10.16.1. Company Overview
    • 10.16.2. Financial Performance
    • 10.16.3. Product Benchmarking
    • 10.16.4. Recent Development
  • 10.17. Teva Pharmaceutical
    • 10.17.1. Company Overview
    • 10.17.2. Financial Performance
    • 10.17.3. Product Benchmarking
    • 10.17.4. Recent Development
  • 10.18. Tolmar Pharmaceuticals
    • 10.18.1. Company Overview
    • 10.18.2. Financial Performance
    • 10.18.3. Product Benchmarking
    • 10.18.4. Recent Development
  • 10.19. Validus Pharmaceuticals
    • 10.19.1. Company Overview
    • 10.19.2. Financial Performance
    • 10.19.3. Product Benchmarking
    • 10.19.4. Recent Development
  • 10.20. Viatris
    • 10.20.1. Company Overview
    • 10.20.2. Financial Performance
    • 10.20.3. Product Benchmarking
    • 10.20.4. Recent Development